Klinikum St Marien Amberg — Clinical Trial Site

33 Registered trials

22 Currently recruiting

Organisation

Klinikum St Marien Amberg

Location

Amberg, Germany

Identifier

ORG-100042740

Address

Mariahilfbergweg 7, 92224, Germany

Departments

Department of Gynecology and obstetrics
Department of Hematology and Medical Oncology
Gynecology and Obstetrics
Hämatologie/Onkologie
Hemato-Oncology
Hematology/Oncology
Innere Medizin und Hämatologie und Onkologie
Klinik für Frauenheilkunde und Geburtshilfe
Klinikum St. Marien Amberg, Mariahilfbergweg 7
Klinikum St. Marien Studienzentrum
MVZ Gesundheitszentrum
MVZ Mariahilfbergweg
N/A
Onkologisches Zentrum
Praxis für Hämatologie und Internistische Onkologie
Strahlentherapie
Studienzentrum
Zertifiziertes Onkologisches Zentrum

Clinical trials at this site (33)

Search interface

ANTELOPE – Atezolizumab/Carboplatin/nab-Paclitaxel vs. Pembrolizumab/Platinum/Pemetrexed in metastatic TTF-1 negative lung adenocarcinoma Ended

2023-505054-17-00 metastatic TTF-1 negative lung adenocarcinoma 6 2023-09-15
The PRESTO Trial - Organ preservation with durvalumab-based immunotherapy in combination with chemoradiation as definitive therapy for early… Ended

2024-512980-29-00 T1-T2N0 esophageal adenocarcinoma including gastroesoph 4 2023-08-28
Combination of Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer wit… Ended

2024-511209-49-00 Patients with hormone receptor positive HER2 negative l 6 2022-04-26
A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRA… Ended

2023-506241-30-00 Advanced Colorectal Cancer with KRAS G12C Mutation 5 2021-11-30
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
DANTE / FLOT8 A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in … Ended

2024-514945-12-00 locally advanced resectable adenocarcinoma of the oesop 10 2018-09-03
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE) Ended

2023-509671-17-00 Breast Cancer 5 2017-07-12
A phase Ib/II single-arm, multicenter study of sacituzumab-govitecan, a TROP-2 targeting antibody linked with SN38, for patients with metast… Ended

2023-505257-40-00 metastatic esophagogastric adenocarcinoma (Stage IV) 9 2024-04-17
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04